Non-invasive prenatal testing (NIPT) is a type of prenatal screening test that assesses the risk of certain chromosomal abnormalities and genetic conditions in the developing fetus with a higher degree of accuracy. This test is a simple blood test performed during the first trimester of pregnancy.

• Trisomy 21 (Down syndrome): This is a genetic disorder caused by an extra copy of chromosome 21, leading to developmental and intellectual challenges.
• Trisomy 18 (Edwards syndrome): Another chromosomal disorder, which results in severe developmental delays and organ abnormalities.
• Trisomy 13 (Patau syndrome): A rare genetic condition causing various birth defects and intellectual disabilities.
• Sex chromosome abnormalities and determine the baby’s sex early in pregnancy.